4.4 Article

Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma

Journal

CLINICAL LUNG CANCER
Volume 23, Issue 1, Pages E9-+

Publisher

CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2021.06.010

Keywords

Large-cell neuroendocrine carcinoma; Small-cell lung carcinoma; Prognosis; Pure neuroendocrine carcinoma; Combined neuroendocrine carcinoma; Multicenter study

Categories

Ask authors/readers for more resources

This study compared the clinical behaviors of combined and pure high-grade NEC and found that they have similar clinical and pathological characteristics as well as similar prognosis.
This study aimed to compare the clinical behaviors of combined and pure high-grade NEC by analyzing approximately 15 years of data from 2 institutions. The combined and pure high-grade NEC showed nearly equivalent clinical and pathological characteristics. In addition, the combined high-grade NEC had prognosis similar to that of the pure high-grade NEC. Our study revealed combined and pure high-grade NEC have biologically and oncologically similar characteristics. Background: The aim of this study was to investigate and compare the clinical behaviors of combined and pure high-grade neuroendocrine carcinoma (large-cell neuroendocrine carcinoma [LCNEC] and small-cell lung carcinoma [SCLC]). Patients and Methods: Data of 132 patients who underwent complete resection for combined or pure highgrade neuroendocrine carcinoma (combined group, 67; pure group, 65) between January 2001 and December 2015 were retrospectively reviewed. The clinicopathological features were analyzed and compared, and the prognoses were assessed by performing the Kaplan-Meier method and Cox regression analysis. Results: The combined and pure groups had nearly equivalent clinicopathological characteristics, specifically, older males with smoking history, almost the same percentage of pleural/lymphatic/vascular invasion, and nearly the same recurrence rates and relapse patterns. The combined group had prognosis equivalent to that of the pure group (5-year overall survival [OS] rates: 61.8% vs. 52.2%, respectively; P = .82 and 5-year recurrence-free survival [RFS] rates: 42.4% vs. 43.9%, respectively; P = .96), and this trend was identified in sub-analyses only for patients with LCNEC, SCLC, and the same pathological stage. Multivariable Cox regression analysis in patients with high-grade neuroendocrine carcinoma revealed that vascular invasion and pathological stage were independent prognostic factors for OS; more importantly, combined and pure histologies were proven to have nearly equivalent associations with prognosis (hazard ratio, 0.96; 95% confidence interval, 0.22to 1.66; P = .96). Results: Combined high-grade neuroendocrine carcinoma had clinical behavior equivalent to those of pure high-grade neuroendocrine carcinoma, with similar clinicopathological characteristics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available